#1 Clinical Trials Search in Europe

Eplerenone

Eplerenone, a medication primarily used to treat heart failure and high blood pressure, has been the subject of numerous clinical trials exploring its potential benefits in various medical conditions. This article summarizes key findings from recent studies investigating eplerenone’s effects on cardiovascular health, eye disorders, and other medical issues. We’ll explore how this drug works, its potential applications, and what researchers have discovered about its efficacy and safety in different patient populations.

Table of Contents

What is Eplerenone?

Eplerenone is a medication that belongs to a class of drugs called mineralocorticoid receptor antagonists. It is also known by the brand name Inspra[1][2]. This medication is primarily used to treat certain heart and blood pressure conditions[2].

How Eplerenone Works

Eplerenone works by blocking the action of a hormone called aldosterone in your body. Aldosterone is responsible for regulating salt and water balance in your body. By blocking this hormone, eplerenone helps to reduce the amount of salt and water your body retains, which can help lower blood pressure and reduce strain on your heart[1].

Additionally, eplerenone has anti-fibrotic properties, which means it can help prevent the formation of excess fibrous tissue in the heart. This is particularly important in certain heart conditions where scarring of the heart muscle can occur[1].

Conditions Treated with Eplerenone

Eplerenone is used to treat several conditions, including:

  • Heart Failure: Eplerenone is used to treat heart failure, particularly in patients who have had a heart attack. It has been shown to improve survival in these patients[10].
  • High Blood Pressure (Hypertension): Eplerenone is approved for the treatment of high blood pressure, especially in obese patients[2].
  • Certain Types of Cardiomyopathy: Research is being conducted on the use of eplerenone in specific types of cardiomyopathy, such as those related to genetic mutations[1].
  • Abdominal Aortic Aneurysm: Studies are investigating whether eplerenone can help limit the progression of abdominal aortic aneurysms, which are dangerous expansions of the main abdominal artery[3].

Dosage and Administration

Eplerenone is typically taken orally in tablet form. The dosage can vary depending on the condition being treated and individual patient factors. Common dosages include:

  • 25mg once daily, which may be increased to 50mg once daily after 4 weeks if needed[2]
  • 50mg once daily for certain conditions[1]

It’s important to take eplerenone exactly as prescribed by your doctor. Your doctor may also recommend regular blood tests to monitor your potassium levels and kidney function while you’re taking this medication[10].

Potential Side Effects

Like all medications, eplerenone can cause side effects. The most important side effects to be aware of include:

  • Elevated potassium levels (hyperkalemia): This is the most significant risk associated with eplerenone. Your doctor will monitor your potassium levels regularly[10].
  • Low blood pressure: Eplerenone can sometimes cause your blood pressure to drop too low[10].
  • Kidney problems: In some cases, eplerenone can affect kidney function[10].

Always inform your doctor of any side effects you experience while taking eplerenone.

Ongoing Research and Potential New Uses

Researchers are continually studying eplerenone to understand its full potential. Some areas of ongoing research include:

  • Heart Protection After Ischemia: Studies are looking at whether eplerenone can help protect the heart from damage after periods of reduced blood flow (ischemia)[4].
  • Eye Conditions: Eplerenone is being studied for its potential in treating certain eye conditions, such as central serous chorioretinopathy, a condition that can cause vision problems[9].
  • Atrial Fibrillation: Research is being conducted to see if eplerenone can help reduce the recurrence of atrial fibrillation (an irregular heart rhythm) in patients with certain heart conditions[5].

These research areas show promise, but it’s important to remember that more studies are needed before eplerenone can be approved for these uses. Always consult with your healthcare provider about the most current and appropriate treatments for your specific condition.

Aspect Details
Primary Uses Heart failure, hypertension
Mechanism of Action Selective aldosterone receptor antagonist
Conditions Under Study Atrial fibrillation, abdominal aortic aneurysms, central serous chorioretinopathy, genetic heart conditions
Key Benefits Potential to reduce blood pressure, decrease fluid retention, improve heart function
Main Side Effects Elevated serum potassium, decreased blood pressure
Dosage in Trials Typically 25-50 mg daily, adjusted based on patient response and tolerance
Unique Applications Being studied for eye disorders and genetic heart conditions
Monitoring Required Regular blood tests for potassium levels, blood pressure checks

FAQ

  • What is eplerenone and how does it work? Eplerenone is a selective aldosterone receptor antagonist. It works by blocking the effects of the hormone aldosterone, which can help reduce blood pressure, decrease fluid retention, and potentially improve heart function in certain conditions.
  • What medical conditions are being studied with eplerenone? Clinical trials are exploring eplerenone's potential in various conditions, including heart failure, hypertension, atrial fibrillation, abdominal aortic aneurysms, central serous chorioretinopathy (an eye disorder), and certain genetic heart conditions.
  • Is eplerenone safe to use? Generally, eplerenone is considered safe when used as prescribed. However, like all medications, it can have side effects. The most important side effects to monitor are elevated serum potassium levels and decreased blood pressure. Patients in clinical trials are closely monitored for these effects.
  • How is eplerenone different from other blood pressure medications? Eplerenone is a specific type of medication called a mineralocorticoid receptor antagonist. Unlike some other blood pressure medications, it targets the hormone aldosterone, which can have unique effects on the body, particularly in relation to fluid balance and heart health.
  • Can eplerenone be used for conditions other than heart problems? Yes, researchers are exploring eplerenone's potential in other conditions. For example, one study is investigating its use in central serous chorioretinopathy, an eye disorder. This shows that the drug's effects may have applications beyond cardiovascular health.

Ongoing Clinical Trials on Eplerenone

  • A Study Testing Drug Combination for Heart Failure in Women Comparing Increased Doses to Standard Care

    Recruiting

    1 1 1 1
    Investigated drugs:
    Italy

  • Study of Optimal Treatment for Uncontrolled Hypertension Using Triple Drug Combinations (Olmesartan/Amlodipine/Hydrochlorothiazide or Perindopril/Indapamide/Amlodipine) with Additional Diuretics

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Poland

  • Study on Eplerenone for Improving Kidney Function in Patients Undergoing Kidney Transplantation

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Comparing Spironolactone and Eplerenone for Patients with Heart Failure and Reduced Ejection Fraction

    Recruiting

    1 1 1 1
    Investigated drugs:
    Denmark

  • Study Comparing Eplerenone and Irbesartan for Lowering Blood Pressure in Obese Patients with Hypertension

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Greece

  • Study on Eplerenone for Heart Health in Kidney Transplant Patients Using Cyclosporine or Tacrolimus

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on the Effect of Eplerenone on Arterial Stiffness in Patients One Year After Kidney Transplant

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on Stopping Medication in Heart Failure Patients with Cardiac Resynchronization Therapy Using Eplerenone, Valsartan, and Bisoprolol Fumarate

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Spain

Glossary

  • Aldosterone: A hormone that helps regulate blood pressure and the balance of fluids and electrolytes in the body.
  • Mineralocorticoid receptor antagonist: A type of medication that blocks the effects of aldosterone in the body.
  • Hypertension: High blood pressure, a condition where the force of blood against artery walls is consistently too high.
  • Atrial fibrillation: An irregular and often rapid heart rate that can increase the risk of strokes, heart failure, and other heart-related complications.
  • Abdominal aortic aneurysm: A weakened and bulging area in the lower part of the aorta, the main artery that carries blood from the heart to the rest of the body.
  • Central serous chorioretinopathy: An eye condition that causes fluid buildup under the retina, potentially leading to vision problems.
  • Cardiomyopathy: A group of diseases that affect the heart muscle, making it harder for the heart to pump blood to the rest of the body.
  • Ejection fraction: A measurement of how much blood the left ventricle pumps out with each contraction, used to assess heart function.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body.
  • Ischemia-reperfusion injury: Tissue damage caused when blood supply returns to tissue after a period of lack of oxygen.

References

  1. https://clinicaltrials.gov/study/NCT01857856
  2. https://clinicaltrials.gov/study/NCT00825188
  3. https://clinicaltrials.gov/study/NCT02345590
  4. https://clinicaltrials.gov/study/NCT02118753
  5. https://clinicaltrials.gov/study/NCT06168994
  6. https://clinicaltrials.gov/study/NCT01971593
  7. https://clinicaltrials.gov/study/NCT03923530
  8. https://clinicaltrials.gov/study/NCT02957435
  9. https://clinicaltrials.gov/study/NCT01822561
  10. https://clinicaltrials.gov/study/NCT00232180